Lack of evidence into paediatric cannabinoid use The researchers found the strongest evidence of cannabinoid benefit in chemotherapy-induced nausea and vomiting, and in epilepsy…
EMA starts safety referral for prostate cancer drug The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has begun two new safety-related referrals…
Older adults at risk of medication-related dry mouth In a meta-analysis of 26 studies, researchers found that medication use was significantly associated with dry mouth…
MHRA launches social media campaign to promote Yellow Card reporting The Medicines and Healthcare products Regulatory Agency has launched a social media campaign to promote the reporting of suspected side effects from over-the-counter medicines…
PPI use not linked to osteoporotic fractures in Barrett’s oesophagus Fractures are not uncommon in patients with the condition, but the rate is not higher than in the general population and is not associated with use of PPIs, researchers concluded.…
Antithrombotic agents associated with haematuria Antithrombotic medications increase risk of complications linked to blood in the urine…
Botox more effective than topiramate for chronic migraine prevention New research suggested botox had greater tolerability compared with topiramate against chronic migraine…
Ten new medicines recommended for approval by EMA The European Medicines Agency Committee for Medicinal Products for Human Use has recommended ten medicines for approval, including one biosimilar and two orphan medicines…
Antidepressants have different adverse effect profiles when used for chronic pain Researchers say that better knowledge of the side effects of low-dose antidepressants is needed to aid the selection of drugs for patients…
Genotype-guided warfarin dosing could improve safety Patients receiving genotype-guided dosing of warfarin were less likely to have a major bleed or die than patients whose dosing was clinically guided.…